ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0657

Assessing Patient Transition Outcomes from a Large Pediatric Rheumatology Center to Adult Healthcare

Mary Robichaux1, Bernard Danna2, Monique Maher2, David McDonald1, Kristiana Nasto1, Alexander Alexander1, Ariel Coleman3, Danielle Guffey1 and Tiphanie Vogel1, 1Baylor College of Medicine, Houston, TX, 2Baylor College of Medicine, Texas Children's Hospital, Houston, TX, 3Texas Children's Hospital, Houston, TX

Meeting: ACR Convergence 2021

Keywords: Pediatric rheumatology, quality improvement, Transition

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 7, 2021

Title: Measures & Measurement of Healthcare Quality Poster (0623–0659)

Session Type: Poster Session B

Session Time: 8:30AM-10:30AM

Background/Purpose: Transitioning children with chronic diseases from pediatric to adult healthcare can be a challenging task, with high morbidity and mortality. In response, we have developed a transition pathway called the Baylor Rheumatology Initiative: Developing and Guiding Engagement (BRIDGE). Through the BRIDGE, patients are introduced to a clinic-specific transition policy, and providers are incentivized to discuss transition planning beginning in early adolescence, with the goal of effective transition to an adult provider. The Transition Planning Tool (TPT) is an electronic medical record-based flowsheet; TPT use is encouraged at clinic visits for patients aged 14-19. Our objective was to assess baseline transition outcomes for a legacy group of transitioned patients and to assess the correlation between TPT utilization and the rate of successful transition.

Methods: Twenty-seven patients who transitioned during the establishment of the BRIDGE pathway were followed for 1 year post-transition to assess the characteristics of their transition. TPT data was reviewed retrospectively for each patient, examining extent of TPT use and completion of TPT elements. We rigorously defined the primary outcome of successful transition as meeting all 3 of the following criteria: 1) first adult rheumatology appointment within 3 months from last pediatric visit; 2) prescriptions refilled from the adult provider within 3 months from transition; and 3) no rheumatology-related emergency (ER) visits or hospital admissions within 1 year of transition. Comparisons were made using Wilcoxon rank sum, Chi-square, and Fisher’s exact tests.

Results: The majority of transitioned patients were female (78%) and privately insured (67%). The most common diagnosis was SLE (33%). Forty-four percent of patients met all goals for successful transition; 67% attended an adult appointment within 3 months (81% did within 4 months), 59% refilled medications within 3 months, and 85% avoided a rheumatology-related admission or ER visit within 1 year. There was no statistical significance between successfully transitioned patients and those who were not in number of times the TPT was accessed, number of unique TPT questions successfully answered, age, sex, diagnosis, insurance type, or disease severity. However, unadjusted logistic regression indicated that completion of some TPT questions, specifically #8 regarding alcohol/non-prescription drug use and #13 knowing who the adult provider will be, was associated with a higher probability of successful transition.

Conclusion: Although there is no significant link between TPT use and successful transition in this legacy cohort, there are some positive signals. For our next step, we will compare these outcomes to those of patients who have been in our formalized BRIDGE program for 1 year or longer before transition. Additionally, over the next quality improvement cycle, we hope to achieve successful transition metrics for 75% of our patients.


Disclosures: M. Robichaux, None; B. Danna, None; M. Maher, None; D. McDonald, None; K. Nasto, None; A. Alexander, None; A. Coleman, None; D. Guffey, None; T. Vogel, None.

To cite this abstract in AMA style:

Robichaux M, Danna B, Maher M, McDonald D, Nasto K, Alexander A, Coleman A, Guffey D, Vogel T. Assessing Patient Transition Outcomes from a Large Pediatric Rheumatology Center to Adult Healthcare [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/assessing-patient-transition-outcomes-from-a-large-pediatric-rheumatology-center-to-adult-healthcare/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/assessing-patient-transition-outcomes-from-a-large-pediatric-rheumatology-center-to-adult-healthcare/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology